Ce. Land, STUDIES OF CANCER AND RADIATION-DOSE AMONG ATOMIC-BOMB SURVIVORS - THE EXAMPLE OF BREAST-CANCER, JAMA, the journal of the American Medical Association, 274(5), 1995, pp. 402-407
A comprehensive program of medical follow-up of survivors of the atomi
c bombings of Hiroshima and Nagasaki, Japan, by the Radiation Effects
Research Foundation (RERF) has produced quantitative estimates of canc
er risk from exposure to ionizing radiation. For breast cancer in wome
n, in particular, the strength of the radiation dose response and the
generally low level of population risk in the absence of radiation exp
osure have led to a clear description of excess risk and its variation
by age at exposure and over time following exposure. Comparisons of R
ERF data with data from medically irradiated populations have yielded
additional information on the influence of population and underlying b
reast cancer rates on radiation-related risk. Epidemiological investig
ations of breast cancer cases and matched controls among atomic bomb s
urvivors have clarified the role of reproductive history as a modifier
of the carcinogenic effects of radiation exposure. Finally, a pattern
of radiation-related risk by attained age among the survivors exposed
during childhood or adolescence suggests the possible existence of a
radiation-susceptible subgroup. The hypothetical existence of such a g
roup is lent plausibility by the results of recent family studies sugg
esting that heritable mutations in certain genes are associated with f
amilial aggregations of breast cancer. The recent isolation and clonin
g of one such gene, BRCA1, makes it likely that the hypothesis can be
tested using molecular assays of archival and other tissue obtained fr
om atomic bomb survivor cases and controls.